3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
6
Acute Kidney Injury
2
Personal Satisfaction
1
Patient Satisfaction
1
Patient Preference
1
Interventions
Surveys and Questionnaires
3
delta 24-sterol reductase
2
Urinary Diversion
2
daratumumab
1
Telemedicine
1
Surgical Procedures, Operative
1
Pilot Projects
1
Mastectomy, Segmental
1
Lead
1
Cystectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Patient Satisfaction
×
daratumumab
×
Clear all
NCT05284591
2024-10-01
MYLENE
iOMEDICO AG
Completed
96 enrolled